Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

NCT00006036 PHASE1 COMPLETED

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of liposomal lurtotecan plus cisplatin in treating patients who have advanced or metastatic solid tumors.

Details

Lead sponsor	NCIC Clinical Trials Group
Phase	PHASE1
Status	COMPLETED
Enrolment	14
Start date	Wed Mar 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Unspecified Adult Solid Tumor, Protocol Specific

Interventions

• cisplatin
• lurtotecan liposome

Countries

Canada